Experimental cell therapy targets Hard-to-Treat cancers
NCT ID NCT05120271
First seen Jan 05, 2026 · Last updated May 20, 2026 · Updated 21 times
Summary
This early-stage trial tests a new treatment called BOXR1030, which uses specially engineered immune cells to attack cancer cells that have a protein called GPC3. The study includes adults with advanced liver, lung, skin, or soft-tissue cancers that have not responded to other treatments. Participants receive the cell therapy after chemotherapy to help the cells work better. The main goals are to check safety and find the best dose.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Baylor Scott and White Research Institute
Dallas, Texas, 75246, United States
-
Beatson Institute for Cancer Research Wolfson Wohl Cancer Research Centre
Glasgow, G61 1BD, United Kingdom
-
Fred Hutchinson Cancer Center - Seattle Cancer Care Alliance (SCCA) Location
Seattle, Washington, 98109, United States
-
Froedtert and Medical College of Wisconsin
Milwaukee, Wisconsin, 53226, United States
-
Hoag Hospital Newport Beach
Newport Beach, California, 92663, United States
-
The Royal Marsden NHS Foundation Trust
London, SW3 6JJ, United Kingdom
-
University College London Hospitals NHS Foundation Trust
London, NW1 2PG, United Kingdom
-
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030-4008, United States
Conditions
Explore the condition pages connected to this study.